1. Home
  2. SRDX vs RPAY Comparison

SRDX vs RPAY Comparison

Compare SRDX & RPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • RPAY
  • Stock Information
  • Founded
  • SRDX 1979
  • RPAY 2006
  • Country
  • SRDX United States
  • RPAY United States
  • Employees
  • SRDX N/A
  • RPAY N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • RPAY Business Services
  • Sector
  • SRDX Health Care
  • RPAY Consumer Discretionary
  • Exchange
  • SRDX Nasdaq
  • RPAY Nasdaq
  • Market Cap
  • SRDX 402.2M
  • RPAY 469.0M
  • IPO Year
  • SRDX 1998
  • RPAY N/A
  • Fundamental
  • Price
  • SRDX $27.75
  • RPAY $4.38
  • Analyst Decision
  • SRDX Buy
  • RPAY Buy
  • Analyst Count
  • SRDX 3
  • RPAY 9
  • Target Price
  • SRDX $43.00
  • RPAY $7.22
  • AVG Volume (30 Days)
  • SRDX 113.5K
  • RPAY 826.5K
  • Earning Date
  • SRDX 11-05-2025
  • RPAY 11-11-2025
  • Dividend Yield
  • SRDX N/A
  • RPAY N/A
  • EPS Growth
  • SRDX N/A
  • RPAY N/A
  • EPS
  • SRDX N/A
  • RPAY N/A
  • Revenue
  • SRDX $120,801,000.00
  • RPAY $310,367,000.00
  • Revenue This Year
  • SRDX N/A
  • RPAY $0.04
  • Revenue Next Year
  • SRDX $3.38
  • RPAY $7.72
  • P/E Ratio
  • SRDX N/A
  • RPAY N/A
  • Revenue Growth
  • SRDX N/A
  • RPAY 1.45
  • 52 Week Low
  • SRDX $26.00
  • RPAY $3.59
  • 52 Week High
  • SRDX $40.39
  • RPAY $9.75
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 29.09
  • RPAY 32.37
  • Support Level
  • SRDX $26.82
  • RPAY $4.46
  • Resistance Level
  • SRDX $28.69
  • RPAY $4.75
  • Average True Range (ATR)
  • SRDX 0.60
  • RPAY 0.19
  • MACD
  • SRDX 0.11
  • RPAY -0.04
  • Stochastic Oscillator
  • SRDX 37.82
  • RPAY 7.50

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About RPAY Repay Holdings Corporation

Repay Holdings Corp is engaged in providing integrated payment processing solutions to verticals that have transaction processing needs. It allows customers to pay through Mobile App, Text, Interactive Voice Response, Virtual Terminal, Hosted Payment Page and Online Customer Portal among others. It operates in two segments Consumer Payments and Business Payments.

Share on Social Networks: